Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration</title><author><name sortKey="Leroy, Valeriane" sort="Leroy, Valeriane" uniqKey="Leroy V" first="Valeriane" last="Leroy">Valeriane Leroy</name><affiliation><nlm:aff id="A1">Inserm, U897, Epidemiologie-Biostatistiques-Bordeaux France</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Institut de Santé Publique, Epidémiologie et Développement (ISPED), Bordeaux Segalen University, Bordeaux, France</nlm:aff></affiliation></author><author><name sortKey="Malateste, Karen" sort="Malateste, Karen" uniqKey="Malateste K" first="Karen" last="Malateste">Karen Malateste</name><affiliation><nlm:aff id="A1">Inserm, U897, Epidemiologie-Biostatistiques-Bordeaux France</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Institut de Santé Publique, Epidémiologie et Développement (ISPED), Bordeaux Segalen University, Bordeaux, France</nlm:aff></affiliation></author><author><name sortKey="Rabie, Helena" sort="Rabie, Helena" uniqKey="Rabie H" first="Helena" last="Rabie">Helena Rabie</name><affiliation><nlm:aff id="A3">Tygerberg Academic Hosp., Stellenbosch University, Cape Town, South Africa</nlm:aff></affiliation></author><author><name sortKey="Lumbiganon, Pagakrong" sort="Lumbiganon, Pagakrong" uniqKey="Lumbiganon P" first="Pagakrong" last="Lumbiganon">Pagakrong Lumbiganon</name><affiliation><nlm:aff id="A4">Khon Kaen University, Thailand</nlm:aff></affiliation></author><author><name sortKey="Ayaya, Samuel" sort="Ayaya, Samuel" uniqKey="Ayaya S" first="Samuel" last="Ayaya">Samuel Ayaya</name><affiliation><nlm:aff id="A5">Moi Teaching and Referral Hosp., Eldoret Kenya</nlm:aff></affiliation></author><author><name sortKey="Dicko, Fatoumata" sort="Dicko, Fatoumata" uniqKey="Dicko F" first="Fatoumata" last="Dicko">Fatoumata Dicko</name><affiliation><nlm:aff id="A6">Hop Gabriel Touré, Bamako, Mali</nlm:aff></affiliation></author><author><name sortKey="Davies, Mary Ann" sort="Davies, Mary Ann" uniqKey="Davies M" first="Mary-Ann" last="Davies">Mary-Ann Davies</name><affiliation><nlm:aff id="A7">Center for Infectious Diseases Epidemiology and Research, School of Public Health and Family Med., University of Cape Town, South Africa</nlm:aff></affiliation></author><author><name sortKey="Kariminia, Azar" sort="Kariminia, Azar" uniqKey="Kariminia A" first="Azar" last="Kariminia">Azar Kariminia</name><affiliation><nlm:aff id="A8">National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia</nlm:aff></affiliation></author><author><name sortKey="Wools Kaloustian, Kara" sort="Wools Kaloustian, Kara" uniqKey="Wools Kaloustian K" first="Kara" last="Wools-Kaloustian">Kara Wools-Kaloustian</name><affiliation><nlm:aff id="A9">Indiana Univ. School of Medicine, Indianapolis, USA</nlm:aff></affiliation></author><author><name sortKey="Aka, Edmond" sort="Aka, Edmond" uniqKey="Aka E" first="Edmond" last="Aka">Edmond Aka</name><affiliation><nlm:aff id="A10">Centre de Prise en Charge, de Recherche et de Formation, CePReF, Abidjan, Côte d'Ivoire</nlm:aff></affiliation></author><author><name sortKey="Phiri, Samuel" sort="Phiri, Samuel" uniqKey="Phiri S" first="Samuel" last="Phiri">Samuel Phiri</name><affiliation><nlm:aff id="A11">Lighthouse Clinic, Lilongwe, Malawi</nlm:aff></affiliation></author><author><name sortKey="Aurpibul, Linda" sort="Aurpibul, Linda" uniqKey="Aurpibul L" first="Linda" last="Aurpibul">Linda Aurpibul</name><affiliation><nlm:aff id="A12">Chiang Mai University, Thailand</nlm:aff></affiliation></author><author><name sortKey="Yiannoutsos, Constantin" sort="Yiannoutsos, Constantin" uniqKey="Yiannoutsos C" first="Constantin" last="Yiannoutsos">Constantin Yiannoutsos</name><affiliation><nlm:aff id="A13">Hopital Albert Royer, Dakar, Sénégal</nlm:aff></affiliation></author><author><name sortKey="Signate Sy, Haby" sort="Signate Sy, Haby" uniqKey="Signate Sy H" first="Haby" last="Signaté-Sy">Haby Signaté-Sy</name><affiliation><nlm:aff id="A14">Pediatric, Adolescent and Maternal AIDS Branch, Center for Research for Mothers and Children,<italic>Eunice Kennedy Shriver</italic> National Institute of Child Health and Human Development, National Institutes of Health, Rockville, USA</nlm:aff></affiliation></author><author><name sortKey="Mofenson, Lynne" sort="Mofenson, Lynne" uniqKey="Mofenson L" first="Lynne" last="Mofenson">Lynne Mofenson</name></author><author><name sortKey="Dabis, Francois" sort="Dabis, Francois" uniqKey="Dabis F" first="François" last="Dabis">François Dabis</name><affiliation><nlm:aff id="A1">Inserm, U897, Epidemiologie-Biostatistiques-Bordeaux France</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Institut de Santé Publique, Epidémiologie et Développement (ISPED), Bordeaux Segalen University, Bordeaux, France</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23187940</idno><idno type="pmc">3556242</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556242</idno><idno type="RBID">PMC:3556242</idno><idno type="doi">10.1097/QAI.0b013e31827b70bf</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">001D65</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001D65</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration</title><author><name sortKey="Leroy, Valeriane" sort="Leroy, Valeriane" uniqKey="Leroy V" first="Valeriane" last="Leroy">Valeriane Leroy</name><affiliation><nlm:aff id="A1">Inserm, U897, Epidemiologie-Biostatistiques-Bordeaux France</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Institut de Santé Publique, Epidémiologie et Développement (ISPED), Bordeaux Segalen University, Bordeaux, France</nlm:aff></affiliation></author><author><name sortKey="Malateste, Karen" sort="Malateste, Karen" uniqKey="Malateste K" first="Karen" last="Malateste">Karen Malateste</name><affiliation><nlm:aff id="A1">Inserm, U897, Epidemiologie-Biostatistiques-Bordeaux France</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Institut de Santé Publique, Epidémiologie et Développement (ISPED), Bordeaux Segalen University, Bordeaux, France</nlm:aff></affiliation></author><author><name sortKey="Rabie, Helena" sort="Rabie, Helena" uniqKey="Rabie H" first="Helena" last="Rabie">Helena Rabie</name><affiliation><nlm:aff id="A3">Tygerberg Academic Hosp., Stellenbosch University, Cape Town, South Africa</nlm:aff></affiliation></author><author><name sortKey="Lumbiganon, Pagakrong" sort="Lumbiganon, Pagakrong" uniqKey="Lumbiganon P" first="Pagakrong" last="Lumbiganon">Pagakrong Lumbiganon</name><affiliation><nlm:aff id="A4">Khon Kaen University, Thailand</nlm:aff></affiliation></author><author><name sortKey="Ayaya, Samuel" sort="Ayaya, Samuel" uniqKey="Ayaya S" first="Samuel" last="Ayaya">Samuel Ayaya</name><affiliation><nlm:aff id="A5">Moi Teaching and Referral Hosp., Eldoret Kenya</nlm:aff></affiliation></author><author><name sortKey="Dicko, Fatoumata" sort="Dicko, Fatoumata" uniqKey="Dicko F" first="Fatoumata" last="Dicko">Fatoumata Dicko</name><affiliation><nlm:aff id="A6">Hop Gabriel Touré, Bamako, Mali</nlm:aff></affiliation></author><author><name sortKey="Davies, Mary Ann" sort="Davies, Mary Ann" uniqKey="Davies M" first="Mary-Ann" last="Davies">Mary-Ann Davies</name><affiliation><nlm:aff id="A7">Center for Infectious Diseases Epidemiology and Research, School of Public Health and Family Med., University of Cape Town, South Africa</nlm:aff></affiliation></author><author><name sortKey="Kariminia, Azar" sort="Kariminia, Azar" uniqKey="Kariminia A" first="Azar" last="Kariminia">Azar Kariminia</name><affiliation><nlm:aff id="A8">National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia</nlm:aff></affiliation></author><author><name sortKey="Wools Kaloustian, Kara" sort="Wools Kaloustian, Kara" uniqKey="Wools Kaloustian K" first="Kara" last="Wools-Kaloustian">Kara Wools-Kaloustian</name><affiliation><nlm:aff id="A9">Indiana Univ. School of Medicine, Indianapolis, USA</nlm:aff></affiliation></author><author><name sortKey="Aka, Edmond" sort="Aka, Edmond" uniqKey="Aka E" first="Edmond" last="Aka">Edmond Aka</name><affiliation><nlm:aff id="A10">Centre de Prise en Charge, de Recherche et de Formation, CePReF, Abidjan, Côte d'Ivoire</nlm:aff></affiliation></author><author><name sortKey="Phiri, Samuel" sort="Phiri, Samuel" uniqKey="Phiri S" first="Samuel" last="Phiri">Samuel Phiri</name><affiliation><nlm:aff id="A11">Lighthouse Clinic, Lilongwe, Malawi</nlm:aff></affiliation></author><author><name sortKey="Aurpibul, Linda" sort="Aurpibul, Linda" uniqKey="Aurpibul L" first="Linda" last="Aurpibul">Linda Aurpibul</name><affiliation><nlm:aff id="A12">Chiang Mai University, Thailand</nlm:aff></affiliation></author><author><name sortKey="Yiannoutsos, Constantin" sort="Yiannoutsos, Constantin" uniqKey="Yiannoutsos C" first="Constantin" last="Yiannoutsos">Constantin Yiannoutsos</name><affiliation><nlm:aff id="A13">Hopital Albert Royer, Dakar, Sénégal</nlm:aff></affiliation></author><author><name sortKey="Signate Sy, Haby" sort="Signate Sy, Haby" uniqKey="Signate Sy H" first="Haby" last="Signaté-Sy">Haby Signaté-Sy</name><affiliation><nlm:aff id="A14">Pediatric, Adolescent and Maternal AIDS Branch, Center for Research for Mothers and Children,<italic>Eunice Kennedy Shriver</italic> National Institute of Child Health and Human Development, National Institutes of Health, Rockville, USA</nlm:aff></affiliation></author><author><name sortKey="Mofenson, Lynne" sort="Mofenson, Lynne" uniqKey="Mofenson L" first="Lynne" last="Mofenson">Lynne Mofenson</name></author><author><name sortKey="Dabis, Francois" sort="Dabis, Francois" uniqKey="Dabis F" first="François" last="Dabis">François Dabis</name><affiliation><nlm:aff id="A1">Inserm, U897, Epidemiologie-Biostatistiques-Bordeaux France</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Institut de Santé Publique, Epidémiologie et Développement (ISPED), Bordeaux Segalen University, Bordeaux, France</nlm:aff></affiliation></author></analytic><series><title level="j">Journal of acquired immune deficiency syndromes (1999)</title><idno type="ISSN">1525-4135</idno><idno type="eISSN">1944-7884</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title><p id="P1">We investigated 18-month incidence and determinants of death and loss-to-follow-up of children after antiretroviral therapy (ART) initiation in a multiregional collaboration in lower-income countries.</p></sec><sec id="S2"><title>Methods</title><p id="P2">HIV-infected children (positive PCR <18 months or positive serology ≥18 months) from IeDEA cohorts, <16 years, initiating ART were eligible. A competing risk regression model was used to analyze the independent risk of two failure types: death and loss-to-follow-up (>6 months).</p></sec><sec id="S3"><title>Findings</title><p id="P3">Data on 13611 children, from Asia (N=1454), East-Africa (N=3114), Southern-Africa (N=6212) and West-Africa (N=2881) contributed 20,417 person-years of follow-up. At 18 months, the adjusted risk of death was 4.3% in East-Africa, 5.4% in Asia, 5.7% in Southern-Africa and 7.4% in West-Africa (<italic>P</italic>=0.01). Age<24 months, WHO stage 4, CD4<10%, attending a private sector clinic, larger cohort size and living in West-Africa were independently associated with poorer survival. The adjusted risk of loss-to-follow-up was 4.1% in Asia, 9.0% in Southern-Africa, 14.0% in East-Africa, and 21.8% in West-Africa (<italic>P</italic> <0.01). Age<12 months, non NNRTI-based ART regimen, WHO stage 4 at ART start, ART initiation after 2005, attending a public sector or a non-urban clinic, having to pay for laboratory tests or antiretroviral drugs, larger cohort size, and living in East or West-Africa were significantly associated with higher loss-to-follow-up.</p></sec><sec id="S4"><title>Conclusion</title><p id="P4">Findings differed substantially across regions but raise overall concerns about delayed ART start, low access to free HIV-services for children, and increased workload on program retention in lower-income countries. Universal free access to ART services and innovative approaches are urgently needed to improve pediatric outcomes at program level.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">100892005</journal-id><journal-id journal-id-type="pubmed-jr-id">21821</journal-id><journal-id journal-id-type="nlm-ta">J Acquir Immune Defic Syndr</journal-id><journal-id journal-id-type="iso-abbrev">J. Acquir. Immune Defic. Syndr.</journal-id><journal-title-group><journal-title>Journal of acquired immune deficiency syndromes (1999)</journal-title></journal-title-group><issn pub-type="ppub">1525-4135</issn><issn pub-type="epub">1944-7884</issn></journal-meta><article-meta><article-id pub-id-type="pmid">23187940</article-id><article-id pub-id-type="pmc">3556242</article-id><article-id pub-id-type="doi">10.1097/QAI.0b013e31827b70bf</article-id><article-id pub-id-type="manuscript">NIHMS425417</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Leroy</surname><given-names>Valeriane</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Malateste</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rabie</surname><given-names>Helena</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Lumbiganon</surname><given-names>Pagakrong</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Ayaya</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Dicko</surname><given-names>Fatoumata</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Davies</surname><given-names>Mary-Ann</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Kariminia</surname><given-names>Azar</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>Wools-Kaloustian</surname><given-names>Kara</given-names></name><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Aka</surname><given-names>Edmond</given-names></name><xref ref-type="aff" rid="A10">10</xref></contrib><contrib contrib-type="author"><name><surname>Phiri</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="A11">11</xref></contrib><contrib contrib-type="author"><name><surname>Aurpibul</surname><given-names>Linda</given-names></name><xref ref-type="aff" rid="A12">12</xref></contrib><contrib contrib-type="author"><name><surname>Yiannoutsos</surname><given-names>Constantin</given-names></name><xref ref-type="aff" rid="A13">13</xref></contrib><contrib contrib-type="author"><name><surname>Signaté-Sy</surname><given-names>Haby</given-names></name><xref ref-type="aff" rid="A14">14</xref></contrib><contrib contrib-type="author"><name><surname>Mofenson</surname><given-names>Lynne</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dabis</surname><given-names>François</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><collab>for the International IeDEA Pediatric Working Group<xref rid="FN2" ref-type="author-notes">*</xref></collab></contrib></contrib-group><aff id="A1"><label>1</label>Inserm, U897, Epidemiologie-Biostatistiques-Bordeaux France</aff><aff id="A2"><label>2</label>Institut de Santé Publique, Epidémiologie et Développement (ISPED), Bordeaux Segalen University, Bordeaux, France</aff><aff id="A3"><label>3</label>Tygerberg Academic Hosp., Stellenbosch University, Cape Town, South Africa</aff><aff id="A4"><label>4</label>Khon Kaen University, Thailand</aff><aff id="A5"><label>5</label>Moi Teaching and Referral Hosp., Eldoret Kenya</aff><aff id="A6"><label>6</label>Hop Gabriel Touré, Bamako, Mali</aff><aff id="A7"><label>7</label>Center for Infectious Diseases Epidemiology and Research, School of Public Health and Family Med., University of Cape Town, South Africa</aff><aff id="A8"><label>8</label>National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia</aff><aff id="A9"><label>9</label>Indiana Univ. School of Medicine, Indianapolis, USA</aff><aff id="A10"><label>10</label>Centre de Prise en Charge, de Recherche et de Formation, CePReF, Abidjan, Côte d'Ivoire</aff><aff id="A11"><label>11</label>Lighthouse Clinic, Lilongwe, Malawi</aff><aff id="A12"><label>12</label>Chiang Mai University, Thailand</aff><aff id="A13"><label>13</label>Hopital Albert Royer, Dakar, Sénégal</aff><aff id="A14"><label>14</label>Pediatric, Adolescent and Maternal AIDS Branch, Center for Research for Mothers and Children,<italic>Eunice Kennedy Shriver</italic> National Institute of Child Health and Human Development, National Institutes of Health, Rockville, USA</aff><author-notes><corresp id="FN1">Corresponding author: Valériane Leroy; MD, PhD, Centre de Recherche INSERM U897, Institut de Santé Publique, Epidémiologie et Développement (ISPED), Université Bordeaux Segalen, Case 11, 146, rue Léo Saignat, 33076 Bordeaux Cedex, FranceTel: 33 (0) 5. 57.57.12.58 (Direct) or 33 (0) 5. 34.57.05.44, Fax: 33 (0) 5. 57.57.45.28, <email>Valeriane.Leroy@isped.u-bordeaux2.fr</email>, Web:<ext-link ext-link-type="uri" xlink:href="http://www.isped.u-bordeaux2.fr">http://www.isped.u-bordeaux2.fr</ext-link></corresp><fn id="FN2"><label>*</label><p>See the International Epidemiologic Databases to Evaluate AIDS (IeDEA) composition in the <xref rid="APP1" ref-type="app">Appendix</xref></p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>9</day><month>1</month><year>2013</year></pub-date><pub-date pub-type="ppub"><day>1</day><month>2</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>2</month><year>2014</year></pub-date><volume>62</volume><issue>2</issue><fpage>208</fpage><lpage>219</lpage><abstract><sec id="S1"><title>Background</title><p id="P1">We investigated 18-month incidence and determinants of death and loss-to-follow-up of children after antiretroviral therapy (ART) initiation in a multiregional collaboration in lower-income countries.</p></sec><sec id="S2"><title>Methods</title><p id="P2">HIV-infected children (positive PCR <18 months or positive serology ≥18 months) from IeDEA cohorts, <16 years, initiating ART were eligible. A competing risk regression model was used to analyze the independent risk of two failure types: death and loss-to-follow-up (>6 months).</p></sec><sec id="S3"><title>Findings</title><p id="P3">Data on 13611 children, from Asia (N=1454), East-Africa (N=3114), Southern-Africa (N=6212) and West-Africa (N=2881) contributed 20,417 person-years of follow-up. At 18 months, the adjusted risk of death was 4.3% in East-Africa, 5.4% in Asia, 5.7% in Southern-Africa and 7.4% in West-Africa (<italic>P</italic>=0.01). Age<24 months, WHO stage 4, CD4<10%, attending a private sector clinic, larger cohort size and living in West-Africa were independently associated with poorer survival. The adjusted risk of loss-to-follow-up was 4.1% in Asia, 9.0% in Southern-Africa, 14.0% in East-Africa, and 21.8% in West-Africa (<italic>P</italic> <0.01). Age<12 months, non NNRTI-based ART regimen, WHO stage 4 at ART start, ART initiation after 2005, attending a public sector or a non-urban clinic, having to pay for laboratory tests or antiretroviral drugs, larger cohort size, and living in East or West-Africa were significantly associated with higher loss-to-follow-up.</p></sec><sec id="S4"><title>Conclusion</title><p id="P4">Findings differed substantially across regions but raise overall concerns about delayed ART start, low access to free HIV-services for children, and increased workload on program retention in lower-income countries. Universal free access to ART services and innovative approaches are urgently needed to improve pediatric outcomes at program level.</p></sec></abstract><kwd-group><kwd>antiretroviral therapy</kwd><kwd>children</kwd><kwd>cohort studies</kwd><kwd>HIV infection</kwd><kwd>mortality</kwd><kwd>loss to follow-up</kwd><kwd>low income countries</kwd><kwd>Asia</kwd><kwd>Africa</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D659 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001D659 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.33. |  |